T8	Exp 92 114	The small molecule S9a
T9	Exp 227 251	the isopropylidine group
T10	Exp 518 522	that
T11	Exp 574 588	the appearance
T12	Exp 811 813	It
T13	Exp 827 831	that
T14	Exp 971 976	which
T15	Exp 832 845	the mechanism
T16	Exp 880 893	the host cell
T17	Exp 1117 1122	which
T18	Exp 1189 1193	that
T19	Exp 1076 1115	the first generation compound Canventol
T20	Exp 1139 1173	the natural compound sarcophytol A
T21	Exp 1244 1259	these compounds
T22	Exp 1411 1416	which
T23	Exp 1525 1529	that
T24	Exp 1385 1409	the other a viral target
T25	Exp 1444 1455	the problem
T26	Exp 1273 1283	This study
R6	Coref Anaphora:T10 Antecedent:T27
R7	Coref Anaphora:T14 Antecedent:T7
R8	Coref Anaphora:T17 Antecedent:T19
R9	Coref Anaphora:T22 Antecedent:T24
R10	Coref Anaphora:T23 Antecedent:T28
T1	Protein 71 80	TNF-alpha
T2	Protein 147 174	tumor necrosis factor-alpha
T3	Protein 176 185	TNF-alpha
T4	Protein 623 626	CD4
T5	Protein 761 770	TNF-alpha
T6	Protein 907 916	TNF-alpha
T7	Protein 937 940	Tat
T27	Exp 500 517	HIV-1 replication
T28	Exp 1519 1524	drugs
